(Q33952053)

English

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin (English)

1 reference

Europe PubMed Central

30 July 2017

1 reference

based on heuristic

inferred from title

author name string

M Ouellet

1

1 reference

Europe PubMed Central

30 July 2017

D Riendeau

2

1 reference

Europe PubMed Central

30 July 2017

M D Percival

3

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

20 November 2001

1 reference

Europe PubMed Central

30 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

30 July 2017

98

1 reference

Europe PubMed Central

30 July 2017

25

1 reference

Europe PubMed Central

30 July 2017

14583-14588

1 reference

Europe PubMed Central

30 July 2017

Prostaglandin H synthase-2 inhibitors interfere with prostaglandin H synthase-1 inhibition by nonsteroidal anti-inflammatory drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Aspirin: new cardiovascular uses for an old drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Purification and characterization of the human recombinant histidine-tagged prostaglandin endoperoxide H synthases-1 and -2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Kinetic basis for selective inhibition of cyclo-oxygenases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

https://api.crossref.org/works/10.1073%2FPNAS.251543298

21 January 2018

Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Prostaglandin G2 levels during reaction of prostaglandin H synthase with arachidonic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

Inhibition of platelet prostaglandin synthetase by oral aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

5 July 2018

PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.251543298

21 January 2018

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.251543298

21 January 2018

A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

29 October 2018

Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.251543298

21 January 2018

Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=64725

29 October 2018

Cumulative antiplatelet effect of low-dose enteric coated aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between thromboxane production, platelet aggregability, and serum concentrations of ibuprofen or flurbiprofen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

My doctor recently recommended that I take low-dose aspirin to minimize the risk of a heart attack or stroke. I routinely take ibuprofen for arthritis pain. Do I need both, and is it safe to combine the two?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/11717412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.251543298

1 reference

Europe PubMed Central

30 July 2017

2001PNAS...9814583O

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33952053&oldid=1773452338"